Brookfield Asset Management Inc. Biomarin Pharmaceutical Inc Transaction History

Brookfield Asset Management Inc.

$11.3 Billion
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$86.68 - $100.3 $10.3 Million - $11.9 Million	-118,545 Reduced 86.31%	18,798 $1.63 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $10.3 Million - $11.9 Million	-118,545 Reduced 86.31%	18,798 $1.63 Million
Q1 2023 Sep 25, 2023	BUY	$87.74 - $117.27 $10.4 Million - $13.9 Million	118,545 Added 630.63%	137,343 $13.4 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $3.36 Million - $4.49 Million	-38,302 Reduced 21.81%	137,343 $13.4 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $2.37 Million - $3.19 Million	29,330 Added 20.05%	175,645 $18.2 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $1.03 Million - $1.22 Million	-12,541 Reduced 7.89%	146,315 $12.4 Million
Q2 2022 Nov 16, 2022	BUY	$71.48 - $86.85 $896,430 - $1.09 Million	12,541 Added 8.57%	158,856 $13.2 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $2.24 Million - $2.72 Million	-31,272 Reduced 16.45%	158,856 $13.2 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $7.09 Million - $8.85 Million	95,426 Added 100.76%	190,128 $14.7 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $1.93 Million - $2.46 Million	26,930 Added 39.74%	94,702 $8.37 Million
Q3 2021 Nov 16, 2021	SELL	$74.77 - $85.47 $1.07 Million - $1.22 Million	-14,255 Reduced 17.38%	67,772 $5.24 Million
Q2 2021 Aug 17, 2021	BUY	$75.51 - $84.79 $818,452 - $919,038	10,839 Added 15.23%	82,027 $6.84 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $1.37 Million - $1.66 Million	18,281 Added 34.55%	71,188 $5.38 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $3.84 Million - $4.77 Million	52,907 New	52,907 $4.64 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Account